FDA’s Hand-Held Rx Counterfeit Detector Could Roll Out To Developing Nations
Executive Summary
Agency meets with USAID stakeholders and wants to maximize the public health impact of its hand-held counterfeit drug detection device, which allows for quick preliminary screening of drug shipments to determine if counterfeit or adulterated product is present.
You may also be interested in...
Gottlieb Showing Capitol Hill Skills With Funding Success
US FDA gains $94m in new funding for international mail facilities, a priority for the commissioner, along with an increase in non-user fee dollars for agency operations.
Track-and-Trace Law: Push Begins For 2015 Exchange Standards
FDA has a tight deadline to finalize guidance on transaction information.
FDA Counterfeit Screening Tool Gets Field Test In Ghana; Corning Prepares Device For Mass Production
FDA currently employs the CD3 in its laboratories and at a number of international mail facilities and other points of entry to the U.S. to screen cosmetics, foods, medical devices and cigarettes, as well as drugs.